Cancer Research

Good News: US Cancer Rates Continue To Drop And Survivors Will Increase 31 Percent By 2024

There is good news for cancer survivors- their numbers continue to grow. There are currently 14.5 million cancer survivors in the USA and that will grow to almost 19 million by 2024, according to the second edition of Cancer Treatment&Survivorship Fac ...

Article - News Staff - Jun 1 2014 - 11:03am

Oncologists Should Talk With Pathologists About Cancer Molecular Testing

As targeted therapies become more available, increasing opportunity exists to match treatments to the genetics of a specific cancer- but oncologists have to know these genetics in order to make the match, which requires molecular testing of patient sample ...

Article - News Staff - Jun 1 2014 - 9:36am

Combination Immunotherapy For Advanced Melanoma- Phase 1b Trial Results Encouraging

Long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results — long-lasting, with high survival rates — according to a presentation at the 2014 annual conference of the Americ ...

Article - News Staff - Jun 2 2014 - 11:13am

TIC10 Promising Cancer Drug With Uncertain Future

The May 26th 2014 issue of Chemical&Engineering News reported on a promising drug with a future to be determined by the courts. Cancer researcher Wafik S. El-Deiry of Pennsylvania State University and Penn State Milton S. Hershey Medical Center and col ...

Blog Post - Scott Beers - Jun 4 2014 - 11:35pm

Why Are Older Women More Vulnerable To Breast Cancer?

Why, as we age, are we more vulnerable to cancer?  You don't think of Lawrence Berkeley National Laboratory- one of the atomic bomb testing facilities- when you think of breast cancer research, but they know cell mutations. A new paper in Cell Report ...

Article - News Staff - Jun 5 2014 - 6:00pm

Prostate Cancer Biomarkers In Seminal Fluid More Accurate Than PSA

A new study finds that seminal fluid- semen- contains biomarkers for prostate cancer, the most common cancer in men.  University of Adelaide research fellow and lead author Dr Luke Selth says the commonly used PSA (prostate specific antigen) test is by it ...

Article - News Staff - Jun 6 2014 - 10:51am

The Abscopal Effect

Dr. Karl Kruszelnicki has described a very interesting case of a cancer patient named Daniel. Daniel was a fit man in his mid 30's and was diagnosed with malignant melanoma. Within two months it had spread to his lymph nodes and within one year had sp ...

Blog Post - Scott Beers - Jun 23 2014 - 8:13am

COST: Calculating The Financial Pain Of Cancer

Cancer care has had lots of known side effects but one goes less discussed- the "financial toxicity", which is the expense, anxiety and loss of confidence confronting those who face large, unpredictable costs, often compounded by decreased abili ...

Article - News Staff - Jun 22 2014 - 4:00am

MTDH Breast Cancer Gene Needs A Partner To Create Tumors

The gene Metadherin- MTDH- which is implicated in promoting the spread of breast cancer tumors, only stimulates tumor growth when the protein made by the gene interacts with a second protein known as SND1, according to a paper in Cancer Cell. Invasive bre ...

Article - News Staff - Jun 29 2014 - 8:30am

Proof Of Concept For New Tuberculosis Therapy

Tuberculosis (TB) remains a major cause of disability and death worldwide. An estimated 8.6 million people fell ill and 1.3 million people died from the disease in 2012, according to the World Health Organization. Although TB is curable, adherence to ther ...

Article - News Staff - Jun 27 2014 - 11:31am